Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries

Imagem de Miniatura
Arquivos
art_GLASBEY_Elective_surgery_system_strengthening_development_measurement_and_validation_2022.PDF (1.98 MB)
Citações na Scopus
27
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
GLASBEY, James C.
ABBOTT, Tom E. F.
ADEMUYIWA, Adesoji
ADISA, Adewale
ALAMEER, Ehab
ALSHRYDA, Sattar
ARNAUD, Alexis P.
BANKHEAD-KENDALL, Brittany
CHAAR, M. K. Abou
CHAUDHRY, Daoud
Citação
LANCET, v.400, n.10363, p.1607-1617, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background The 2015 lancet Commission on global surgery identified surgery and anaesthesia as indispensable parts of holistic health-care systems. However, COVID-19 exposed the fragility of planned surgical services around the world, which have also been neglected in pandemic recovery planning. This study aimed to develop and validate a novel index to support local elective surgical system strengthening and address growing backlogs. Methods First, we performed an international consultation through a four-stage consensus process to develop a multidomain index for hospital-level assessment (surgical preparedness index; SPI). Second, we measured surgical preparedness across a global network of hospitals in high-income countries (HICs), middle-income countries (MICs), and low-income countries (LICs) to explore the distribution of the SPI at national, subnational, and hospital levels. Finally, using COVID-19 as an example of an external system shock, we compared hospitals' SPI to their planned surgical volume ratio (SVR; ie, operations for which the decision for surgery was made before hospital admission), calculated as the ratio of the observed surgical volume over a 1-month assessment period between June 6 and Aug 5,2021, against the expected surgical volume based on hospital administrative data from the same period in 2019 (ie, a pre-pandemic baseline). A linear mixed-effects regression model was used to determine the effect of increasing SPI score. Findings In the first phase, from a longlist of 103 candidate indicators, 23 were prioritised as core indicators of elective surgical system preparedness by 69 dinicians (23133%) women; 46 [67%] men; 41 from HICs, 22 from MICs, and six from LICs) from 32 countries. The multidomain SPI included 11 indicators on facilities and consumables, two on staffing, two on prioritisation, and eight on systems. Hospitals were scored from 23 (least prepared) to 115 points (most prepared). In the second phase, surgical preparedness was measured in 1632 hospitals by 4714 clinicians from 119 countries. 745 (45.6%) of 1632 hospitals were in MICs or LICs. The mean SPI score was 84.5 (95% CI 84.1-84.9), which varied between HIC (88.5 189.0-88.0]), MIC (81.8 [82.5-81.1]), and LIC (66.8 [64.9-68.7]) settings. In the third phase, 1217 (74.6%) hospitals did not maintain their expected SVR during the COVID-19 pandemic, of which 625 (51.4%) were from HIC, 538 (44.2%) from MIC, and 54 (4.4%) from LIC settings. In the mixed-effects model, a 10-point increase in SPI corresponded to a 3.6% (95% CI 3.0-4.1; p<0.0001) increase in SVR. This was consistent in HIC (4.8% [4.1-5.5]; p<0.0001), MIC (2.8 [2.0-3.7]; p<0.0001), and LIC (3.8 [1.3-6 . 7%]; p<0.0001) settings. Interpretation The SPI contains 23 indicators that are globally applicable, relevant across different system stressors, vary at a subnational level, and are collectable by front-line teams. In the case study of COVID-19, a higher SPI was associated with an increased planned surgical volume ratio independent of country income status, COVID-19 burden, and hospital type. Hospitals should perform annual self-assessment of their surgical preparedness to identify areas that can be improved, create resilience in local surgical systems, and upscale capacity to address elective surgery backlogs.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/52941
Referências
  1. [Anonymous], 2022, LANCET, V399, P605, DOI 10.1016/S0140-6736(22)00271-9
  2. [Anonymous], 2020, LANCET ONCOL, V21, P999, DOI 10.1016/S1470-2045(20)30396-X
  3. Bagenal J, 2022, BMJ-BRIT MED J, V377, DOI 10.1136/bmj.o995
  4. Bollyky TJ, 2022, LANCET, V399, P1489, DOI 10.1016/S0140-6736(22)00172-6
  5. Bouchard ME, 2021, J PUBLIC HEALTH POL, V42, P493, DOI 10.1057/s41271-021-00292-z
  6. Chaudhry R, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100464
  7. COVID Surg Collaborative, 2022, LANCET, V399, P233, DOI 10.1016/S0140-6736(21)02836-1
  8. COVIDsurg Collaborative, 2020, LANCET, V396, P27, DOI 10.1016/S0140-6736(20)31182-X
  9. Ehsan AN, 2022, LANCET, V399, P1380, DOI 10.1016/S0140-6736(22)00521-9
  10. Fowler AJ, 2021, BRIT J SURG, V108, P97, DOI 10.1093/bjs/znaa012
  11. Glasbey JC, 2021, LANCET ONCOL, V22, P1507, DOI 10.1016/S1470-2045(21)00493-9
  12. Glasbey JC, 2021, BRIT J SURG, V108, P88, DOI 10.1093/bjs/znaa051
  13. Glasbey JC, 2021, J CLIN ONCOL, V39, P66, DOI 10.1200/JCO.20.01933
  14. Groen RS, 2012, WORLD J SURG, V36, P1970, DOI 10.1007/s00268-012-1591-3
  15. Haldane V, 2017, LANCET, V389, P1513, DOI 10.1016/S0140-6736(17)30946-7
  16. Hale T, 2021, NAT HUM BEHAV, V5, P529, DOI 10.1038/s41562-021-01079-8
  17. Hamadani JD, 2020, LANCET GLOB HEALTH, V8, pE1380, DOI 10.1016/S2214-109X(20)30366-1
  18. Hanna TP, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4087
  19. Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
  20. Iverson KR, 2019, BRIT J SURG, V106, pE81, DOI 10.1002/bjs.11032
  21. Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1
  22. Kieny MP, 2015, LANCET, V385, P91, DOI 10.1016/S0140-6736(14)62479-X
  23. Kim EK, 2022, BMJ GLOB HEALTH, V7, DOI 10.1136/bmjgh-2021-008222
  24. Knight SR, 2021, LANCET, V397, P387, DOI 10.1016/S0140-6736(21)00001-5
  25. Koo TK, 2017, J CHIROPR MED, V16, P346, DOI 10.1016/j.jcm.2017.10.001
  26. Kruk ME, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2323
  27. Lai AG, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-043828
  28. Lal A, 2021, LANCET, V397, P61, DOI 10.1016/S0140-6736(20)32228-5
  29. Mangipudi S, 2020, LANCET GLOB HEALTH, V8, pE1123, DOI 10.1016/S2214-109X(20)30298-9
  30. Mattingly AS, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.38038
  31. Mazingi D, 2020, WORLD J SURG, V44, P2451, DOI 10.1007/s00268-020-05627-7
  32. Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X
  33. Mohanan M, 2021, JAMA-J AM MED ASSOC, V325, P1001, DOI 10.1001/jama.2021.0332
  34. Mwananyanda L, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n334
  35. National Confidential Enquiry into Patient Outcome and Death, 2004, NCEPOD CLASS INT
  36. Nepogodiev D, 2020, BRIT J SURG, V107, P1440, DOI 10.1002/bjs.11746
  37. Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002
  38. Osen H, 2011, WORLD J SURG, V35, P500, DOI 10.1007/s00268-010-0918-1
  39. Qin RX, 2022, LANCET REG HEALTH-W, V22, DOI 10.1016/j.lanwpc.2022.100407
  40. Quintana AV, 2021, LANCET PLANET HEALTH, V5, pE852, DOI 10.1016/S2542-5196(21)00289-8
  41. Waggoner J, 2016, ACAD MED, V91, P663, DOI 10.1097/ACM.0000000000001092
  42. WHO, 2021, COVID 19 STRAT PREP

Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/IOT
Artigos e Materiais de Revistas Científicas - LIM/24
Carregar mais